Document Detail


Increased plasma concentrations of platelet factor 4 in coronary artery disease: a measure of in vivo platelet activation and secretion.
MedLine Citation:
PMID:  6973419     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Previous studies have shown that there is both a significant shortening in platelet survival and a measured hyperactivity to platelet-aggregating agents in patients with documented coronary artery disease compared with control groups. We used a recently described radioimmunoassay for the platelet-secreted protein platelet factor 4 (PF4) to study 162 patients with documented coronary artery disease. There was a significant increase in plasma PF4 concentrations in patients with documented coronary artery disease compared with angiographically normal patients (8.7 vs 16 ng/ml, respectively, n = 121), but as in previous studies of platelet survival, we could not correlate elevated plasma PF4 concentration and the severity or site of the coronary artery disease. In addition, there was no correlation with left ventricular function, serum cholesterol or the type of angina. Patients with confirmed acute myocardial infarction had no significant difference in mean plasma PF4 concentrations compared with similar groups of coronary disease patients who had prolonged chest pain or chronic stable angina. Coronary artery bypass grafting in a subgroup of patients did not affect the mean plasma PF4 concentration during 1 year of follow-up after bypass surgery, but medical therapy for angina with increasing doses of propranolol and nitrates significantly reduced PF4 concentration in another subgroup of patients who were not considered to be candidates for surgical therapy.
Authors:
S P Levine; J Lindenfeld; J B Ellis; N M Raymond; L S Krentz
Related Documents :
810719 - Medical versus surgical therapy for acute coronary insufficiency. a randomized study.
1993779 - Reactivity of eccentric and concentric coronary stenoses in patients with chronic stabl...
16205449 - Systemic inflammatory markers in acute coronary syndrome: association with cardiovascul...
2897819 - Calcium antagonists for angina pectoris.
15378129 - Current medical management of chronic stable angina.
11711459 - Patients with acute coronary syndromes express enhanced cd40 ligand/cd154 on platelets.
19862639 - Cardiovascular magnetic resonance t2 signal abnormalities in left ventricular balloonin...
24581099 - Wearable cardioverter defibrillator: a life vest till the life boat (icd) arrives.
3879349 - Localization of post-infarction myocardial ischemia by 201tl emission computed tomography.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Circulation     Volume:  64     ISSN:  0009-7322     ISO Abbreviation:  Circulation     Publication Date:  1981 Sep 
Date Detail:
Created Date:  1981-10-25     Completed Date:  1981-10-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  626-32     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angina Pectoris / blood,  drug therapy,  physiopathology
Calcium / analysis*,  physiology
Cholesterol / blood
Coronary Artery Bypass
Coronary Disease / blood*,  physiopathology
Drug Therapy, Combination
Follow-Up Studies
Heart / radiography
Heart Ventricles / physiopathology
Humans
Nitrates / therapeutic use
Platelet Aggregation*
Propranolol / therapeutic use
Radioimmunoassay
Chemical
Reg. No./Substance:
0/Nitrates; 525-66-6/Propranolol; 57-88-5/Cholesterol; 7440-70-2/Calcium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evidence for the natural transmission of influenza A virus from wild ducts to swine and its potentia...
Next Document:  Induction of O-deethylase activity as an index to exposure to coal-derived products and trace enviro...